Advocacy News

CEO Marilyn G. Geller’s testimony before the House Appropriations Subcommittee has helped secure report language in the House’s version of the 2020 Labor-HHS-Education bill demanding that the National Institute of Health (NIH) report to Congress in 90 days on its plans to aid celiac disease patients. This acknowledgment that celiac disease is a serious condition…

As a member of the National Coalition of Autoimmune Patients Groups (NCAPG), a coalition founded by the American Autoimmune Related Diseases Association (AARDA), the Celiac Disease Foundation signed onto the proposed rule comments from I Am Essential that would dramatically change the regulations that implement Section 1557, the anti-discrimination provision of the Affordable Care Act. The…

All over the country, parents are getting ready to send their children back to school. Our children, Alexander Solomon, Amanda Solomon, and Draya Ramer, have celiac disease. Returning to school presents special challenges every year…challenges that are magnified if a child is starting a new school or even moving to a new classroom. That is why we are…

On June 3, 2019, Marilyn G. Geller, CEO of the Celiac Disease Foundation, submitted Outside Witness Testimony to the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.

      Outside Witness Testimony – Fiscal Year 2020 Appropriations Prepared By Marilyn G. Geller, CEO, Celiac Disease Foundation Prepared for the Subcommittee on Labor, Health and Human Services, Education and Related Agencies Committee on Appropriations United States Senate June 3, 2019 ______________________________ Chairman Blunt, Ranking Member Murray, and distinguished Members of the Subcommittee,…